Month: May 2024

Snaige AB publishes Consolidated Interim Financial Statements for Q1 2024 (unaudited). Attached:Consolidated interim financial statements of Snaigė AB for the first quarter of 2024 (unaudited); Confirmation of responsible personsGeneral managerDarius VarnasTel. nr.  +370 315 56200AttachmentsConfirmation of responsible persons_2024-05-27Snaigė AB_Consolidated interim financial statements_2024 Q1

Invalda INVL had equity of EUR 182.8 million at the end of March 2024, or EUR 15.23 per share. The figures were 39% and 37% larger, respectively, than a year earlier. Invalda INVL had an unaudited net profit of EUR 4.7 million in the first quarter of the year, which is 4.1 times more than the same period last year when net profit amounted to EUR 1.1 million. “It was an ordinary quarter. We worked actively with our assets under management and new opportunities, generating profit both for our clients and for the company,” Invalda INVL CEO Darius Šulnis says. Client assets under management by the leading Baltic asset management group’s companies totalled EUR 970.9 million at the end of March 2024. Gains of EUR 27.5 million were earned for the group’s clients in the quarter. The asset management and family office business Invalda INVL’s revenue...

In the first quarter of 2024, AUGA group, AB and its subsidiaries (hereinafter – the Group) had sales revenue of EUR 19.74 million, compared to EUR 19.96 million in the same period of 2023. The Group’s gross profit in the first quarter of 2024 was EUR 2.71 million, compared to EUR 1.90 million a year earlier. The Group’s EBITDA in the reporting period was EUR 4.26 million. In the same period last year it was EUR 2.68 million. “The financial results for the first quarter of 2024 show positive trends. As we announced last quarter, the Group has been focusing on reviewing the efficiency of individual segments for some time. Therefore, by mid-last year, we began to cultivate half of the arable land using regenerative conventional farming, and in 2024, we decided to transform one-third of the livestock segment into conventional,...

MIAMI, May 31, 2024 (GLOBE NEWSWIRE) — OPKO Health, Inc. (Nasdaq: OPK) announced today that management will be participating in the Jefferies Global Healthcare Conference, being held June 4-6, 2024 at the Marriott Marquis in New York City. Management will be holding one-on-one meetings with investors and will be participating in a fireside discussion on Thursday, June 6th at 10:30 a.m. Eastern time. The fireside chat will be webcast live and available for replay in the Investors section of OPKO Health’s website and accessible by clicking here. About OPKO Health OPKO is a multinational biopharmaceutical and diagnostics company that seeks to establish industry-leading positions in large, rapidly growing markets by leveraging its discovery, development, and commercialization expertise and novel and proprietary technologies. For more...

TORONTO, May 31, 2024 (GLOBE NEWSWIRE) — MacDonald Mines Exploration Ltd. (TSX-V: BMK, OTC: MCDMF) (“MacDonald Mines” or the “Company”), further to its press release of May 25, 2024 (the “Prior Press Release”), provides an update on the Company’s investigations into the reporting inconsistencies in certain drill core assay results (“Assay Reporting Inconsistencies”) from its Scadding Gold Project. The original certificates from the three certified laboratories used during the exploration work at the Scadding Gold Project have now been received and reviewed. This has allowed for the comparison of the assay results reported in MacDonald Mines drilling database, press releases and other continuous disclosure documents, for the Scadding Gold Project with the assay results reported in the original assay certificates. The Company is...

MDNA11 demonstrates durable response in pancreatic cancer patient with 100% regression of target and non-target lesions for over 104 weeks and continues to show remission 4 months after stopping treatment Melanoma patient continues to show sustained 100% regression of target lesions Dose escalation in combination with KEYTRUDA® is now enrolling at the next higher dose of 90g/kg following absence of any dose limiting toxicities at 60g/kg MDNA11 shows significant increases in stemness, central and effector memory and markers of enhanced effector function in circulating CD8+ T and NK cells, all of which are critical for achieving meaningful and durable anti-cancer response.   Analysis of gene expression signatures from pretreatment and on-treatment paired biopsies show that cancer promoting pathways were degraded while immune-related pathways...

SYDNEY, Australia and New York, NY, May 31, 2024 (GLOBE NEWSWIRE) — Btab Ecommerce Group, Inc., an e-commerce company (OTC: BBTT) (“BBTT” or the “Company”), and Integrated Wellness Acquisition Corp, a special purpose acquisition company (NYSE: WEL) (“WEL” or “Integrated Wellness”), today announced that they have entered into a definitive business combination agreement (the “BCA”) providing for a business combination between WEL and BBTT (the “Transaction”). Upon completion of the Transaction, WEL will be renamed Btab Ecommerce Holdings, Inc and is expected to continue to be listed on NYSE. The Transaction values BBTT at an equity value of U.S. $250 million. Transaction Overview Under the terms of the BCA, a wholly owned subsidiary of WEL will merge with and into BBTT, with BBTT surviving the merger and...